SCHEMBL708407

SCHEMBL708407

CS(=O)(=O)N1CCC(Nc2n[nH]c3c2nc(-c2c(F)cccc2F)c2cc(C(=O)O)ccc23)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.43
CDK2 P24941 9/20 0.42
CDK1 P06493 5/20 0.42
CDK4 P11802 4/20 0.42
CCND1 P24385 4/20 0.42
CNR1 P21554 1/20 0.40
TDO2 P48775 1/20 0.39
CCNE1 P24864 6/20 0.38
CSNK2A1 P68400 5/20 0.38
CSNK2A2 P19784 2/20 0.37
CSNK2B P67870 2/20 0.37
CCNB1 P14635 2/20 0.36
CCNB2 O95067 1/20 0.36
CCNE2 O96020 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
PTGER3 P43115 1/20 0.36
GRM4 Q14833 1/20 0.36
CCND3 P30281 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL704772 0.93 CDK2 (0.44) MAPK14CDK2CDK1CDK4CCND1
SCHEMBL31448368 0.93 CDK2 (0.44) MAPK14CDK2CDK1CDK4CCND1
SCHEMBL2680449 0.92 MAPK14 (0.43) MAPK14CDK2CDK1CDK4CCND1
SCHEMBL703570 0.91 MAPK14 (0.42) MAPK14CDK2CDK1CDK4CCND1
SCHEMBL705987 0.90 MAPK14 (0.41) MAPK14CDK2CDK1CDK4CCND1
SCHEMBL703045 0.89 MAPK14 (0.51) MAPK14CDK2CDK1CDK4CCND1
SCHEMBL2680427 0.89 MAPK14 (0.41) MAPK14CDK2CDK1CDK4CCND1
SCHEMBL702868 0.87 MAPK14 (0.46) MAPK14CDK2CDK1CDK4CCND1
SCHEMBL698984 0.87 MAPK14 (0.43) MAPK14CDK2CDK1CDK4CCND1
SCHEMBL708901 0.86 MAPK14 (0.43) MAPK14CDK2CDK1CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421864-B1 1-PYRAZOLO[4,3-C]ISOQUINOLINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2014-08-06 EP disclosed
EP-2421864-A1 1-PYRAZOLO[4,3-C]ISOQUINOLINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-02-29 EP disclosed
WO-2010122272-A1 1-PYRAZOLO[4,3-C]ISOQUINOLINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2010-10-28 WO disclosed